Trade AstraZeneca ^AZN

Aurora Investment Counsel Takes $2.53 Million Position in Astrazeneca Plc $AZN

Assetmark Inc. Has $37.69 Million Stake in Astrazeneca Plc $AZN

Is a £500k Stocks and Shares ISA enough to retire in style?

Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch?

Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

AstraZeneca Stock And Two UK Cash Flow Picks Trading Below Fair Value

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

SouthState Bank Corp Sells 63,327 Shares of Astrazeneca Plc $AZN

Barings LLC Makes New $27.79 Million Investment in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Stake Reduced by Nwam LLC - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Attractive Growth Profile Positions AstraZeneca PLC (AZN) as Opportunity

Attractive Growth Profile Positions AstraZeneca PLC (AZN) as an Investment Bet

Astrazeneca Plc $AZN Position Lowered by Marks Group Wealth Management Inc

Principal Financial Group Inc. Decreases Position in Astrazeneca Plc $AZN

AZN: Trial Setbacks And Oncology Deals Will Shape Medium Term Credibility

Astrazeneca Plc $AZN Shares Sold by Marks Group Wealth Management Inc - Daily Political

ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS)

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models

Checchi Capital Advisers LLC Decreases Stake in Astrazeneca Plc $AZN

169,590 Shares in Astrazeneca Plc $AZN Purchased by Maryland State Retirement & Pension System

Checchi Capital Advisers LLC Trims Stake in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by Calamos Advisors LLC

AMG National Trust Bank Has $4.72 Million Stake in Astrazeneca Plc $AZN - Zolmax

Calamos Advisors LLC Trims Position in Astrazeneca Plc $AZN - Stock Observer

Recent Research Analysts' Ratings Changes for Astrazeneca (AZN) - Daily Political

Maryland State Retirement & Pension System Buys Shares of 169,590 Astrazeneca Plc $AZN - Daily Political

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma

Promising Manufacturing Stocks To Research - July 14th - Zolmax

Sequoia Financial Advisors LLC Sells 19,406 Shares of Astrazeneca Plc $AZN - Zolmax

HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead

IP Federation elects Philips licensing leader as new president

Samsung Electronics denies report that it is exploring US listing

AstraZeneca Secures $1.5 Billion Licensing Deal for Revolutionary Lung Cancer Drug Zegfrovy from China's Dizal Pharma, ETPharma

Astrazeneca Plc $AZN Shares Bought by Diversify Wealth Management LLC

Bleakley Financial Group LLC Sells 23,183 Shares of Astrazeneca Plc $AZN

AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill

AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion | Morningstar

Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

Dizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy

Calamos Wealth Management LLC Sells 4,322 Shares of Astrazeneca Plc $AZN - Stock Observer

Carnegie Investment Counsel Reduces Position in Astrazeneca Plc $AZN - Daily Political

AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN) | Morningstar

HSBC downgrades AstraZeneca after key trial failure

AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'

Astrazeneca Plc $AZN Shares Sold by Triglav Investments D.O.O.

Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Citizens National Bank Trust Department Sells 13,426 Shares of Astrazeneca Plc $AZN - Daily Political

AstraZeneca Stock And 2 UK Value Shares Trading Below Cash Flow Estimates

AstraZeneca helps spark £3bn UK life sciences investment boom

Pittenger & Anderson Inc. Sells 32,448 Shares of Astrazeneca Plc $AZN

Rossmore Private Capital Sells 32,709 Shares of Astrazeneca Plc $AZN

AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage

Ionis Pharmaceuticals (IONS) Faces A Key Setback As Eplontersen Misses In Phase 3

Money Concepts Capital Corp Lowers Stake in Astrazeneca Plc $AZN

AstraZeneca Stock And 2 UK Cash Flow Picks Trading Below Fair Value

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) After Rival ATTR-CM Setback And New Partnerships

AstraZeneca's trial flop raises bigger questions around its pipeline

Is Alnylam Pharmaceuticals (ALNY) Cheap As Rival Trial Failure Shifts ATTR CM Expectations?

Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Top Pharmaceutical Stocks To Follow Now - July 10th

Manufacturing Stocks Worth Watching - July 10th - Stock Observer

AZN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving AstraZeneca | Morningstar

Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure

AstraZeneca wiped £19bn from its value in a day - what happened and what's next for the stock?

Astrazeneca Plc $AZN Shares Acquired by Channing Global Advisors LLC

Astrazeneca Plc $AZN Position Reduced by Azzad Asset Management Inc. ADV

AstraZeneca Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AstraZeneca (AZN) | Morningstar

AstraZeneca and PureHealth to activate Rare Diseases Centre of Excellence in Abu Dhabi

The PRECISE European initiative for cancer-vulnerability mapping and prediction

Ionis and AstraZeneca: Shares Tank as Phase 3 ATTR-CM Trial Falls Short of Expectations | Morningstar

Health Care Down on Rotation Out of Defensive Sectors - Health Care Roundup | Morningstar

BridgeBio stock jumps after rival heart drug fails key trial

AstraZeneca Slides 9.9% After Heart Drug Trial Misses Late-Stage Goal

Dow Jones Top Company Headlines at 1 PM ET: 'Expectations on Every Calorie:' How PepsiCo's CEO Is Navigating GLP-1s and Inflation | AstraZeneca, ... | Morningstar

Ionis Stock Slides 20% After Phase 3 ATTR-CM Trial Misses Primary Endpoint

FTSE 100 held back by AstraZeneca trial setback

AstraZeneca's Wainua fails key heart disease trial, shares tumble

UK Stocks Drop as AstraZeneca's Heart Drug Trial Results, Geopolitical Tensions Weigh

Dow Jones Top Company Headlines at 11 AM ET: 'Expectations on Every Calorie'-PepsiCo's CEO Is Navigating GLP-1s and Inflation | AstraZeneca, ... | Morningstar

Astrazeneca (NYSE:AZN) Shares Gap Down - Should You Sell?

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

Ionis Pharmaceuticals (IONS) Stock Plummets 20% Following Failed Heart Disease Trial

AstraZeneca (AZN) Stock Plunges 9% as Wainua Trial Misses Primary Endpoint

AstraZeneca Falls After Wainua Heart Disease Trial Fails

Futures Rise, Oil Drops As Markets Ignore Latest Middle East Airstrikes

Stocks making the biggest moves premarket: AZN, PEP, CRM, LEVI

FTSE 100 Down 0.8%; AstraZeneca Tanks Nearly 10%

AstraZeneca Shares Slide After Wainua Treatment Fails Heart Disease Trial | Morningstar

AstraZeneca sees stock market value slump by more than £20bn after drug setback

Personal CFO Solutions LLC Sells 9,628 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by Frank Rimerman Advisors LLC

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk